Stryker Corp (SYK)
325.17
-2.28
(-0.70%)
USD |
NYSE |
Apr 19, 15:08
Stryker Cash from Financing (Quarterly): -286.00M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -286.00M |
| September 30, 2023 | -422.00M |
| June 30, 2023 | -405.00M |
| March 31, 2023 | -481.00M |
| December 31, 2022 | -446.00M |
| September 30, 2022 | -543.00M |
| June 30, 2022 | -753.00M |
| March 31, 2022 | 993.00M |
| December 31, 2021 | -288.00M |
| September 30, 2021 | -348.00M |
| June 30, 2021 | -676.00M |
| March 31, 2021 | -1.053B |
| December 31, 2020 | -1.057B |
| September 30, 2020 | -242.00M |
| June 30, 2020 | 2.056B |
| March 31, 2020 | -768.00M |
| December 31, 2019 | 2.363B |
| September 30, 2019 | -225.00M |
| June 30, 2019 | -188.00M |
| March 31, 2019 | -1.947B |
| December 31, 2018 | 2.28B |
| September 30, 2018 | -179.00M |
| June 30, 2018 | -917.00M |
| March 31, 2018 | 145.00M |
| December 31, 2017 | -272.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -345.00M |
| June 30, 2017 | -40.00M |
| March 31, 2017 | -137.00M |
| December 31, 2016 | -52.00M |
| September 30, 2016 | -948.00M |
| June 30, 2016 | -1.00M |
| March 31, 2016 | 3.259B |
| December 31, 2015 | 79.00M |
| September 30, 2015 | -251.00M |
| June 30, 2015 | -317.00M |
| March 31, 2015 | -734.00M |
| December 31, 2014 | -82.00M |
| September 30, 2014 | -56.00M |
| June 30, 2014 | 584.00M |
| March 31, 2014 | 183.00M |
| December 31, 2013 | -153.00M |
| September 30, 2013 | -105.00M |
| June 30, 2013 | -93.00M |
| March 31, 2013 | 651.00M |
| December 31, 2012 | -63.00M |
| September 30, 2012 | -110.00M |
| June 30, 2012 | -148.00M |
| March 31, 2012 | -128.00M |
| December 31, 2011 | -139.00M |
| September 30, 2011 | 388.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.057B
Minimum
Dec 2020
2.363B
Maximum
Dec 2019
-145.74M
Average
-405.00M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 15.00M |
| Haemonetics Corp | 109.43M |
| Abbott Laboratories | -2.052B |
| Zimmer Biomet Holdings Inc | -251.40M |
| Edwards Lifesciences Corp | -413.20M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.528B |
| Cash from Investing (Quarterly) | -152.00M |
| Free Cash Flow | 3.136B |
| Free Cash Flow Per Share (Quarterly) | 3.604 |
| Free Cash Flow to Equity (Quarterly) | 1.078B |
| Free Cash Flow to Firm (Quarterly) | 1.383B |
| Free Cash Flow Yield | 2.51% |